Spexis AG
Develops therapeutics for rare diseases, oncology, and antimicrobial resistance.
SPEX | SW
Overview
Corporate Details
- ISIN(s):
- CH0106213793
- LEI:
- 391200S8HJE1I96FIG04
- Country:
- Switzerland
- Address:
- Hegenheimermattweg 125, 4123 Allschwil
- Website:
- https://www.polyphor.com/
- Sector:
- Manufacturing
Description
Spexis AG is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for rare diseases and oncology. The company leverages its expertise in macrocycle technology to create novel drug candidates designed to address high unmet medical needs. Its pipeline is advanced through a strategy that includes in-house discovery, development, in-licensing, and the acquisition of promising molecules. The primary therapeutic areas of interest include rare diseases and cancer, with an additional focus on antimicrobial resistance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-13 01:00 |
Spexis gibt vielversprechende präklinische Daten für Balixafortide in Kombinati…
|
German | 13.4 KB | ||
| 2022-10-18 07:30 |
Spexis to present at BIO-Europe 2022
|
English | 9.6 KB | ||
| 2022-10-18 02:00 |
Spexis to present at BIO-Europe® 2022
|
English | 7.6 KB | ||
| 2022-09-22 07:15 |
Spexis announces positive renal impairment clinical trial results with balixafo…
|
English | 15.3 KB | ||
| 2022-09-22 02:00 |
Spexis announces positive renal impairment clinical trial results with balixafo…
|
English | 13.1 KB | ||
| 2022-09-22 02:00 |
Spexis mit positiven Ergebnissen für Balixafortide bei Niereninsuffizienz
|
German | 14.4 KB | ||
| 2022-09-06 07:15 |
Spexis provides business update and announces financial results for the first h…
|
English | 23.7 KB | ||
| 2022-09-06 02:00 |
Spexis provides business update and announces financial results for the first h…
|
English | 20.8 KB | ||
| 2022-09-06 02:00 |
Spexis informiert über die aktuelle Geschäftsentwicklung und gibt Finanzergebni…
|
German | 24.1 KB | ||
| 2022-08-31 07:30 |
Spexis announces presentation of half-year 2022 financial results and participa…
|
English | 11.9 KB | ||
| 2022-07-28 07:15 |
Spexis provides business update
|
English | 19.3 KB | ||
| 2022-07-28 02:00 |
Spexis provides business update
|
English | 16.7 KB | ||
| 2022-07-25 19:25 |
Spexis announces business update call to be held on July 28th
|
English | 10.0 KB | ||
| 2022-07-25 02:00 |
Spexis announces business update call to be held on July 28th
|
English | 8.2 KB | ||
| 2022-07-25 02:00 |
Spexis kündigt für den 28. Juli ein Update zur Geschäftsentwicklung an
|
German | 8.3 KB |
Automate Your Workflow. Get a real-time feed of all Spexis AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Spexis AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Spexis AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-21 | N/A | Executive member | Other | None | N/A |
Peer Companies
